Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ganeden Biotech

Ganeden Biotech
1997 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of patented probiotic ingredients designed for making over-the-counter probiotic medicines. The company's personal care ingredient is produced through a proprietary fermentation process and contains the optimal combination of naturally derived metabolites enabling its patients in the treatment of abdominal pain and bloating, ulcerative colitis, Crohn's disease and irritable bowel disease.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 5800 Landerbrook Drive
  • Suite 300
  • Mayfield Heights, OH 44124
  • United States

+1 (440) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ganeden Biotech’s full profile, request a free trial.

Ganeden Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Oct-2017 0000 Completed Generating Revenue
2. Secondary Transaction - Private 0000 Completed Generating Revenue
1. Later Stage VC (Series A) 05-Nov-2007 $12M $12M 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Ganeden Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Ganeden Biotech Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OmniActive Health Technologies Private Equity-Backed Mumbai, India 0000 0000 0000
000000000 Corporation Irvine, CA 000 000.00 000000000 000.00
00000000 Formerly VC-backed Nacka, Sweden 000000&0
0000000000 0000000 Corporate Backed or Acquired Somerset, United Kingdom 000 000000&0
00000 0000000000 0 Formerly PE-Backed East Hanover, NJ 000 0000 00000.
To view this company’s complete list of competitors, request access »

Ganeden Biotech Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cane Investment Partners Growth/Expansion Minority 000 0000 000000 0
Capital Resource Partners PE/Buyout 000 0000 000000 0
DSM Venturing Corporate Venture Capital Minority 000 0000 000000 0
Fairbridge Venture Partners Venture Capital Minority 000 0000 000000 0
yet2Ventures Venture Capital Minority 000 0000 000000 0

Ganeden Biotech Executive Team (8)

Name Title Board
Seat
Contact
Info
Andrew Lefkowitz Chief Executive Officer
Michael Bush President
Sean Farmer Co-Founder, Chief Scientific Officer & Director
Joe Bradley Senior Vice President
Gerti Soderquist Marketing Vice President

2 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Ganeden Biotech Board Members (2)

Name Representing Role Since Contact
Info
John Shields Self Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »